Buy Indegene; target of Rs 708: Motilal Oswal

Motilal Oswal's research report on IndegeneGlobal life science and pharma companies prefer to onboard external agencies like Indegene to reduce operational costs, accelerate go-tomarket, access specialized global talent, and manage the spike in content volume during the drug launch and drop during…